TABLE 1

Candidate Biomarkers for PET Imaging of T-Cell Responses

TargetTypeStageApplication
OX40Surface biomarkerPreclinicalTILs, GVHD
CTLA-4Surface biomarkerPreclinicalTILs, GVHD
CD3Surface biomarkerPreclinicalTILs
CD4Surface biomarkerPreclinicalTILs, IBD, HSCT, lymphoid organs
CD8Surface biomarkerPreclinical/clinicalTILs, lymphoid organs
ICOSSurface biomarkerPreclinicalTILs, CAR-T
PD-1Surface biomarkerPreclinical/clinicalTILs
IL-2RSurface biomarkerPreclinical/clinicalTILs, ONNV, lymphoid organs
TCRmuSurface biomarkerPreclinicalCAR-T
VLA4Surface biomarkerPreclinicalTuberculosis
Granzyme BSecreted biomarkerPreclinicalTILs
dCKIntracellular enzymePreclinical/clinicalTILs, autoimmune hepatitis
dGKIntracellular enzymePreclinical/clinicalGVHD, TILs, RA
HSV1-tkReporter gene/encoded protein size (46 kDa)Preclinical/clinicalCAR-T
HSV1-sr39tkReporter gene/encoded protein size (42 kDa)PreclinicalRA
PSMAReporter gene/encoded protein size (100 kDa)PreclinicalCAR-T
NETReporter gene/encoded protein size (69 kDa)PreclinicalTILs
SSTR2Reporter gene/encoded protein size (41 kDa)PreclinicalCAR-T
DHFRReporter gene/encoded protein size (18 kDa)PreclinicalCAR-T
NISReporter gene/encoded protein size (69 KDa)PreclinicalCAR-T
2D12.5/G54CReporter gene/encoded protein size (52 kDa)PreclinicalCAR-T
  • TIL = tumor infiltrating lymphocytes; CTLA-4 = cytotoxic T-lymphocyte antigen-4; IBD = inflammatory bowel disease; HSCT = hematopoietic stem cell transplantation; IL-2R = interleukin-2 receptors; ONNV = o’nyong-nyong virus; TCRmu = murine T-cell receptor β-domain; VLA4 = very late antigen-4; dCK = deoxycytidine kinase; dGK = deoxyguanosine kinase; PSMA = prostate-specific membrane antigen; NET = norepinephrine transporter; SSTR2 = somatostatin receptor 2; DHFR = dihydrofolate reductase enzyme; NIS = sodium iodide symporter; 2D12.5/G54C = antilanthanoid-DOTA antibody.

  • PET tracers targeting biomarkers listed here are also discussed in references 3, 22, and 35.